Page 4 - covid19_M

Assessment of problems in healthcare
In this section, the reviewer is asked to comment on whether one or more specific types of problem(s) No Yes Uncertain
were identified and, if so, to indicate whether any led to harm.
Were there any problems with the care of the patient? (Please tick) □ □
(if you answer ‘No’ please stop here)
Problem in assessment, investigation or diagnosis (including assessment of □ □
pressure ulcer risk, venous thromboembolism (VTE) risk, history of falls)

Did the problem lead to harm? □ □ □
Admission Ongoing End-of-life
and initial care care
In which phase(s) did the problem occur? assessment
□ □ □

Problem with medication / IV fluids / electrolytes / oxygen □ □
Did the problem lead to harm? □ □ □
Admission Ongoing End-of-life
and initial care care
In which phase(s) did the problem occur? assessment
□ □ □
Problem related to treatment and management plan (including prevention of □ □
pressure ulcers, falls, VTE)
Did the problem lead to harm? □ □ □
Admission Ongoing End-of-life
and initial care care
In which phase(s) did the problem occur? assessment
□ □ □

Problem with infection management □ □
Did the problem lead to harm? □ □ □
Admission Ongoing End-of-life
and initial care care
In which phase(s) did the problem occur? assessment
□ □ □
Problem in clinical monitoring (including failure to plan, to undertake, or to □ □
recognise and respond to changes)
Did the problem lead to harm? □ □ □
Admission Ongoing End-of-life
and initial care care
In which phase(s) did the problem occur? assessment
□ □ □
Problem in resuscitation following a cardiac or respiratory arrest (including
□ □
cardiopulmonary resuscitation (CPR))
Did the problem lead to harm? □ □ □
Admission Ongoing End-of-life
and initial care care
In which phase(s) did the problem occur? assessment
□ □ □
Problem of any other type not fitting the categories above (including □ □
communication and organisational issues)
Did the problem lead to harm? □ □ □
Admission Ongoing End-of-life
and initial care care
In which phase(s) did the problem occur? assessment
□ □ □

4 Mortality review committee for COVID 19 19 June 2020